Quest Diagnostics (DGX) Revenue — Quarter Ended Jun 30, 2024
Revenue for the quarter rose compared to both the immediately preceding quarter and the same quarter one year earlier. The sequential growth was modest, while the year-over-year increase was more pronounced.
Key takeaway
Quarter ended Jun 30, 2024 · FY2024 Q2
Revenue for the quarter rose compared to both the immediately preceding quarter and the same quarter one year earlier. The sequential growth was modest, while the year-over-year increase was more pronounced.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.4B
Revenue reported for this quarter.
Quarter-over-quarter
+1.3%
Change from the immediately preceding quarter.
Year-over-year
+2.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$9.3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2023 | $2.3B | -7.7% |
| Dec 31, 2023 | $2.3B | -1.9% |
| Mar 31, 2024 | $2.4B | +1.5% |
| Jun 30, 2024 | $2.4B | +2.5% |
Revenue performance
The company generated higher revenue in the current quarter, reflecting a continuation of the upward trend seen in the prior quarter. The growth relative to the same period last year was stronger than the sequential gain.
Quarterly comparison
Compared to the previous quarter, revenue increased slightly. Versus the year-ago quarter, the revenue improvement was larger.
What to watch
The trend data shows that revenue has been fluctuating in recent quarters, with the current quarter reaching the highest level in the trailing four quarters.